What will occur if a person take salbutamol inhaler then after 1 hour take propranolol tablet.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Here is a detailed answer on what happens when salbutamol is followed by propranolol:

Salbutamol Inhaler Followed by Propranolol Tablet (1 Hour Later)

The Core Problem: Direct Pharmacological Antagonism

These two drugs work at the same receptors but in opposite directions, making the combination dangerous:
DrugClassReceptor ActionEffect
SalbutamolSelective beta-2 agonistActivates beta-2 receptorsBronchodilation, airway opening
PropranololNon-selective beta-blockerBlocks both beta-1 and beta-2 receptorsBronchoconstriction, cardiac slowing

What Happens Step-by-Step

After salbutamol inhaler (time 0):
  • Beta-2 receptors in bronchial smooth muscle are activated
  • Airways dilate, breathing improves
  • Salbutamol's inhaled effect typically lasts 4-6 hours (short-acting)
After propranolol tablet (1 hour later): Propranolol absorbs from the gut and blocks beta-2 receptors in the lungs directly - reversing the bronchodilation salbutamol just achieved. Multiple effects occur:
  1. Bronchoconstriction / Bronchospasm - the most dangerous effect. Propranolol blocks the beta-2 receptors that salbutamol was stimulating. Airways narrow. This can be life-threatening in an asthma or COPD patient. As confirmed by authoritative textbooks: "Propranolol should not be used in asthmatics, or together with salbutamol and other selective beta-2 agonists." - Scott-Brown's Otorhinolaryngology Head & Neck Surgery
  2. Bradycardia - propranolol's beta-1 blockade slows heart rate. Salbutamol at high doses can cause a mild tachycardia; propranolol will reverse this and potentially overshoot to bradycardia.
  3. Antagonism of bronchodilatory rescue - because propranolol occupies the beta-2 receptors, further doses of salbutamol will have reduced or no effect. This is the most clinically dangerous scenario: a patient in bronchospasm reaches for their rescue inhaler and it doesn't work.
  4. Hyperkalemia (mild risk) - Salbutamol shifts potassium into cells (lowering serum K+), while propranolol blocks this effect and may push serum K+ back up. This has implications for patients with cardiac or renal issues.
  5. Masking of hypoglycemia signs - propranolol blocks tachycardia, which is one of the warning signs of low blood sugar (important if the patient is diabetic).

Who is at Greatest Risk?

  • Asthma patients: Using salbutamol as a bronchodilator then taking propranolol can trigger a fatal asthma attack. This is a well-recognized absolute contraindication.
  • COPD patients: Similar risk of severe bronchospasm.
  • Healthy people: May tolerate small propranolol doses with some reduction in bronchodilator effect, but still at risk of bronchospasm at higher doses.
Harrison's Principles of Internal Medicine (2025) notes: "The earliest beta blocker drugs were relatively nonselective blockers of beta-adrenergic receptors, including the heart (beta-1 receptors) and lungs (beta-2 receptors). They are rarely prescribed [for certain conditions] due to the potential for bronchospasm."

Clinical Bottom Line

The combination of salbutamol + propranolol is contraindicated, especially in patients with asthma or reversible airway disease. Taking propranolol just 1 hour after salbutamol means:
  • The propranolol will overcome and reverse the bronchodilation
  • It can trigger severe, potentially fatal bronchospasm
  • If bronchospasm occurs, salbutamol rescue doses will not work because propranolol is blocking the very receptors salbutamol needs
  • Emergency treatment would require ipratropium (anticholinergic) or IV magnesium sulfate, not more salbutamol
If a patient genuinely needs both a beta-blocker and a bronchodilator (e.g., for cardiac reasons + asthma), a cardioselective beta-1 blocker (like metoprolol or bisoprolol) is used instead of propranolol - these have much less effect on lung beta-2 receptors.
This is a shared conversation. Sign in to Orris to start your own chat.